Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.
about
Blood-brain barrier disruption: mechanistic links between Western diet consumption and dementiaTriptolide preserves cognitive function and reduces neuropathology in a mouse model of Alzheimer's diseaseLCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteinsApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damageCharacterizing blood-brain barrier perturbations after exposure to human triglyceride-rich lipoprotein lipolysis products using MRI in a rat model.Insulin, cognition, and dementiaLong-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction.The vascular contribution to Alzheimer's disease.Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseDifferential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activityNovel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research.Amyloid precursor protein mediated changes in intestinal epithelial phenotype in vitro.A diet enriched in docosahexanoic Acid exacerbates brain parenchymal extravasation of apo B lipoproteins induced by chronic ingestion of saturated fats.Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer diseaseThe Postprandial Effects of a Moderately High-Fat Meal on Lipid Profiles and Vascular Inflammation in Alzheimer's Disease Patients: A Pilot Study.Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease.Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway.Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease.Neurometabolic roles of ApoE and Ldl-R in mouse brainChronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer's disease.Deficits in hippocampal-dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosisNutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type miceTreatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice.Progesterone reduces depression-like behavior in a murine model of Alzheimer's Disease.The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads convergedNeutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine.Amyloid precursor protein modulates macrophage phenotype and diet-dependent weight gainInsulin resistance and pathological brain ageing.Mechanisms of action of brain insulin against neurodegenerative diseases.Lipidomics of Alzheimer's disease.Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's diseaseProbucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding.Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses.Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.Interrelationship between Mini-Mental State Examination scores and biochemical parameters in patients with mild cognitive impairment and Alzheimer's disease.Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta.Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer's mouse model.
P2860
Q26826813-E3C4B368-E372-4BF9-AEE8-6C94FDAAD38AQ28543501-8AAD69C2-8DCF-4008-83C8-7407DDB02FB6Q28595076-C49C80CA-36E8-4DA7-9702-6B87E9EA6D1BQ28742107-6F8D2F38-1850-4B91-A98E-2314E70837CDQ30488441-3B7E5953-FD1C-4D34-BE92-95AE882F51F5Q33604874-AAE12EBD-D2CA-43D1-856D-E84A2FACB40FQ33738241-41102430-101B-4E92-80F3-BFD82C50D377Q34178526-78EF10B9-5253-4A2E-9AB6-34827C57C062Q34533985-8C65FEF5-1BAA-477E-BD36-4B91C12E767EQ35040568-86A2B9D7-216D-47BA-A04A-2EB88828A91EQ35101132-A350BBA8-5DBC-4517-9F2E-77A91B4E497DQ35152303-C679714A-66C1-4E70-A502-05B7C1F00F36Q35550684-64D7EB7D-EA21-42E7-8FE8-A812ACE54118Q35621563-16FA8DAC-F294-4BAF-9F6B-1A5AD8C7FF6DQ35634147-14A1186C-911E-4F4C-A95D-E715DE0E6106Q35665512-1E66ACF2-03B1-459F-93D9-3B433B4D43D4Q35860977-EE8FB7FF-6218-4D64-AF4B-BE63A920B8C7Q35976702-1144663A-AD4D-4486-B25C-30FA6FA60ADFQ36465116-5B531A22-EBC5-43A6-B1DC-15D2EC43B4E0Q36522825-30A604BF-6E5C-4E3B-9A30-87EBABD3AD18Q36591408-68DA7FE1-2A27-41FC-A18A-A8E73EF99D96Q36717090-DCD4B635-4C98-40F8-9C31-E4B4B7A328DFQ36958137-508B668D-9A6E-4D7A-8EFA-0CF603A80C2EQ36958249-BE1E6621-51DA-4082-8845-117081A11A35Q37220808-C4672839-A9E8-4643-B153-24D9703CBFE0Q37280580-DAC579DC-53E0-4C5C-9562-6C83BF05F83AQ37357640-6B8935CC-2DE8-4056-894A-7A117B15CD82Q37406905-BD69BE71-27C8-4E1C-91F4-0301E0915FE5Q37681861-5D94B2F3-97AE-4616-86AC-2E080682EB31Q37942690-D3102585-7E91-4C2A-983D-1EE8E963CDE0Q38176522-99BC982A-3DAA-4EB8-A34F-DC38FB71B5D4Q38191024-045AE783-8B6B-4438-A977-4E6DCC152503Q41428334-CCD78865-21AE-40CC-821F-3F4B6AEC5A99Q44440536-CF6C639D-33F6-446A-81C6-4747B93647CCQ45415934-70CBB23F-CB02-4D5D-A5E3-FE6C3E34C84DQ46397777-84944D48-C069-4482-BDC4-ADA9565570FDQ47288599-76BAA08B-8BF0-4197-844E-2E1065E9DA0FQ47860207-F9B2C23A-7ADE-42E6-A53F-E88B22A57554Q48423106-55BEA489-5570-4878-9774-DDB38D98593AQ48456453-9EC1A0B1-1767-49B7-A515-50C388CEE390
P2860
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@en
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@nl
type
label
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@en
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@nl
prefLabel
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@en
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@nl
P2093
P50
P1476
Elevated plasma triglyceride l ...... ith abundant A beta in plasma.
@en
P2093
Braydon L Burgess
Cheryl L Wellington
David Westaway
Fudan Miao
Gavin H K Tansley
Jeniffer Y Chan
Kathryn E Naus
Miranda van Eck
Sean A McIsaac
P304
P356
10.1016/J.NBD.2006.06.007
P577
2006-08-08T00:00:00Z